Expanded Surveillance for Pediatric Infectious Diseases
This grant funds a network of U.S. institutions to track and analyze pediatric respiratory and gastrointestinal viruses, evaluating prevention methods and informing public health strategies through hospital and clinic surveillance.
Funder: Centers for Disease Control and Prevention - ERA
Due Dates (Anticipated): December 2026 (Full application deadline, projected)
Funding Amounts: Estimated total funding: $40,000,000 | Expected awards: 7 | Typical award: $850,000–$1,140,000/year
Summary: Supports a U.S. network to conduct active surveillance of pediatric respiratory and enteric viral illnesses and evaluate prevention product effectiveness.
Key Information: Forecasted opportunity; all dates and details are subject to change—verify on the program page.
Description
This forecasted opportunity from the Centers for Disease Control and Prevention (CDC) will fund a network of U.S. institutions to conduct standardized, prospective, and active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The focus is on respiratory and enteric viruses among pediatric patients seeking healthcare. The program aims to generate robust estimates regarding the effectiveness of prevention products (such as vaccines for influenza, rotavirus, and RSV) and to inform public health strategies, best practices, and recommendations for pediatric viral illness prevention and treatment.
Applicants must apply for the required Core Component (Component A), which supports surveillance in inpatient and emergency department settings. Optional components allow for additional outpatient surveillance and studies on immune response and immunization.
